Brief: Hisamitsu Pharmaceutical Co's Operating Profit For March-May Qtr Likely Slid 12 Pct - Nikkei
26/06/2018 22:39
June 27 (Reuters) - Hisamitsu Pharmaceutical Co Inc
4530.T :
* HISAMITSU PHARMACEUTICAL'S MARCH-MAY QUARTER SALES LIKELY
SLIPPED 3% TO ABOUT 35 BILLION YEN - NIKKEI
* HISAMITSU PHARMACEUTICAL CO OPERATING PROFIT FOR MARCH-MAY
QUARTER LIKELY SLID 12 PERCENT ON YEAR TO ABOUT 4.5 BILLION YEN
- NIKKEI
Source text for Eikon: ID:nNen1qrLqz
Further company coverage: 4530.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO